contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


finansinspektionen-flaggningsmeddelande-i-medivir-aktiebolag-36

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Medivir develops drugs with a focus on cancer diseases where the medical needs are great. The drug candidates are directed towards indication areas where available treatment methods are limited or absent. Medivir focuses on the development of fostrox, a drug candidate that has been designed to selectively treat cancer cells in the liver. The company was founded in 1988 and is headquartered in Huddinge.

Medivir

Flaggningsmeddelande i Medivir AktiebolagAnmälan om förvärv eller överlåtelse av finansiella instrument. Emittent556238-4361 Medivir AktiebolagInstrumentSE0020181014 aktieInnehavareHallberg ...

<div align="center"><div align="left"><div align="center"><img border="0" src="http://mb.cision.com/Public/13135/0/aca45bcefa0046bb_org.gif" alt="Finansinspektionen"></div><div><img border="0" width="575" src="http://mb.cision.com/Public/13135/0/9287b61ccc5d0383_org.gif" alt="---" height="1"></div><div><div><h1>Flaggningsmeddelande i Medivir Aktiebolag</h1>Anmälan om förvärv eller överlåtelse av finansiella instrument.<br><br><table width="512"><tbody><tr><td><b>Emittent</b></td><td class="tvalue">556238-4361 Medivir Aktiebolag</td></tr><tr><td><b>Instrument</b></td><td class="tvalue">SE0020181014 aktie</td></tr><tr><td><b>Innehavare</b></td><td class="tvalue">Hallberg Management AB</td></tr><tr><td colspan="2">&nbsp;</td></tr><tr><td colspan="2"><b>Före transaktionen</b></td></tr><tr><td>Antal aktier</td><td class="tvalue">94&nbsp;000&nbsp;000</td></tr><tr><td>Antal rösträtter</td><td class="tvalue">94&nbsp;000&nbsp;000</td></tr><tr><td colspan="2">&nbsp;</td></tr><tr><td colspan="2"><b>Transaktionen</b></td></tr><tr><td>Skäl för flaggning</td><td class="tvalue">Bolagshändelse</td></tr><tr><td>Datum</td><td class="tvalue">2026-02-27</td></tr><tr><td>Gränsvärde för antal aktier</td><td class="tvalue">20 %</td></tr><tr><td>Gränsvärde för rösträtter</td><td class="tvalue">20 %</td></tr><tr><td colspan="2">&nbsp;</td></tr><tr><td colspan="2"><b>Efter transaktionen:</b></td></tr><tr><td colspan="2">Antal</td></tr><tr><td>&nbsp;-&nbsp;aktier</td><td class="tvalue">94&nbsp;000&nbsp;000</td></tr><tr><td>&nbsp;-&nbsp;direkt innehavda rösträtter</td><td class="tvalue">94&nbsp;000&nbsp;000</td></tr><tr><td>&nbsp;-&nbsp;indirekt innehavda rösträtter</td><td class="tvalue">0</td></tr><tr><td colspan="2">Andel</td></tr><tr><td>&nbsp;-&nbsp;aktier</td><td class="tvalue">17,37133 %</td></tr><tr><td>&nbsp;-&nbsp;direkt innehavda rösträtter</td><td class="tvalue">17,44241 %</td></tr><tr><td>&nbsp;-&nbsp;indirekt innehavda rösträtter</td><td class="tvalue">0 %</td></tr><tr><td colspan="2"> </td></tr><tr><td colspan="3"><table><tbody><tr><td colspan="3">Fördelning av totalt innehav</td></tr><tr><td class="tlabel"></td><td class="tvalue1">Andel rösträtter</td><td class="tvalue2">Antal aktier genom:</td></tr><tr><td class="tlabel">Aktier, samt övriga instrument enligt LHF 4 kap. 2§ första stycket&nbsp;1</td><td class="tvalue1">17,44241&nbsp;%</td><td class="tvalue2">94&nbsp;000&nbsp;000</td></tr><tr><td class="tlabel">Finansiella instrument enligt LHF 4 kap. 2§ första stycket&nbsp;2</td><td class="tvalue1"></td><td class="tvalue2"></td></tr><tr><td class="tlabel">Finansiella instrument enligt LHF 4 kap. 2§ första stycket&nbsp;3</td><td class="tvalue1"> </td><td class="tvalue2"></td></tr><tr><td class="tlabel">&nbsp;-&nbsp;Fysisk avvecklade</td><td class="tvalue1"></td><td class="tvalue2"></td></tr><tr><td class="tlabel">&nbsp;-&nbsp;Kontantavräknade</td><td class="tvalue1"></td><td class="tvalue2"></td></tr><tr><td colspan="3">&nbsp;</td></tr><tr><td class="tlabel">TOTALT</td><td class="tvalue1">17,44241&nbsp;%</td><td class="tvalue2">94&nbsp;000&nbsp;000</td></tr><tr><td colspan="3">&nbsp;</td></tr><tr><td class="tlabel">Totalt antal rösträtter</td><td class="tvalue1"></td><td class="tvalue2"></td></tr></tbody></table></td></tr><tr><td colspan="2">&nbsp;</td></tr><tr><td colspan="2"><b>Kommentar</b></td></tr><tr><td colspan="2">Den riktade nyemissionen till Carl Bennet AB under februari 2026 har medfört en ökning av antalet utestående aktier och röster i Medivir AB. Till följd av emissionen har Hallberg Management AB:s innehav av aktier och röster i bolaget underskridit tröskelvärdet om 20 procent, vilket innebär att anmälningsskyldighet uppstår enligt lagen om handel med finansiella instrument. Medivir AB offentliggjorde det nya totala antalet utestående aktier och röster den 27 februari 2026.</td></tr><tr><td colspan="2">&nbsp;</td></tr></tbody></table><br><br>Innehavare rapporterar flaggning via <a href="http://fi.se">fi.se</a>. Innehållet i flaggningsmeddelandet svarar innehavaren för.<br>Informationen skickades av Cision och finns även i FI:s databas Börsinformation, <a href="http://www.fi.se/borsinformation">www.fi.se/borsinformation</a>.</div></div><div><img border="0" width="575" src="http://mb.cision.com/Public/13135/0/9287b61ccc5d0383_org.gif" alt="---" height="1"></div></div></div>